Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
96.75
-0.03 (-0.03%)
Dec 26, 2025, 4:00 PM EST - Market closed
Revvity Employees
Revvity had 11,000 employees as of December 29, 2024. The number of employees decreased by 500 or -4.35% compared to the previous year.
Employees
11,000
Change (1Y)
-500
Growth (1Y)
-4.35%
Revenue / Employee
$255,761
Profits / Employee
$21,589
Market Cap
10.97B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 11,000 | -500 | -4.35% |
| Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
| Dec 31, 2022 | 16,700 | 0 | - |
| Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
| Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
| Dec 31, 2019 | 13,000 | 500 | 4.00% |
| Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
| Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
| Dec 31, 2016 | 8,000 | 0 | - |
| Dec 31, 2015 | 8,000 | 300 | 3.90% |
| Dec 31, 2014 | 7,700 | 100 | 1.32% |
| Dec 31, 2013 | 7,600 | 100 | 1.33% |
| Dec 31, 2012 | 7,500 | 300 | 4.17% |
| Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
| Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
| Dec 31, 2009 | 8,200 | 300 | 3.80% |
| Dec 31, 2008 | 7,900 | -800 | -9.20% |
| Dec 31, 2007 | 8,700 | 200 | 2.35% |
| Dec 31, 2006 | 8,500 | 500 | 6.25% |
| Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
| Dec 31, 2004 | 10,000 | 0 | - |
| Dec 31, 2003 | 10,000 | -700 | -6.54% |
| Dec 31, 2002 | 10,700 | -100 | -0.93% |
| Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
| Dec 31, 2000 | 12,500 | 500 | 4.17% |
| Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
| Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
| Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
| Dec 31, 1996 | 15,000 | 0 | - |
| Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
| Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
| Dec 31, 1993 | 32,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RVTY News
- 10 days ago - Revvity to Present at J.P. Morgan Healthcare Conference - Business Wire
- 12 days ago - Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery - Business Wire
- 26 days ago - Revvity, Inc. (RVTY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 6 weeks ago - Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 6 weeks ago - Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy - Business Wire
- 6 weeks ago - Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities - Business Wire
- 2 months ago - Revvity Analysts Increase Their Forecasts After Q3 Earnings - Benzinga